Jim DeMase Sr. National Technical Sales Manager Precision BioLogic Inc. Dartmouth, Nova Scotia, CANADA Hemophilia is a disease that strikes rich and pour, royals or commoners. We will review the types, symptoms, and diagnosis and common treatment options available today. The laboratory testing methods and their clinical applications in laboratory test diagnosis will be outlined and new recombinant factor replacement products will be highlighted as they pose new challenges for the hemostasis lab. Case studies will be used to relate to real world situations. Objectives: Describe the types of Hemophilia that affect patients. Explain the range of Hemophilia symptoms along with diagnosis and treatment. Relate the methods and clinical applications for mixing studies and factor inhibitors. Workshop #2 Intermediate Wednesday, May 16 8:00 9:30 am 1.5 Contact Hours – Subject Area Hematology – The Expanded CBC in Hematology: How Immature Cell Counts Help Complete the Patient Picture Robert Oleksy Senior Clinical Specialist Sysmex The clinical utilization of immature cell counts used in conjunction with mature cell count data may assist clinicians with assessing pathophysiological mechanisms and help complete the overall patient picture. This session will discuss newer hematology parameters currently available to clinicians outside of the standard Complete Blood Count (CBC). The presentation will include information on Immature Granulocyte (IG) percent and absolute counts, Reticulocyte Hemoglobin content, Immature Platelet Fraction (IPF) and Immature Platelet Count (IPC). The review will include clinical evidence and case studies related to the parameters and discuss the impact the authors found in their studies. Objectives: Describe novel hematology parameters and their derivation. Investigate the evidence for their clinical utility. Discuss how new information can be applied to patient care. Workshop #3 Intermediate Wednesday, May 16 8:00 9:30 am 1.5 Contact Hours – Subject Area Immunology – Primary Immunodeficiency Disease: Underdiagnosed at any age Dr. Anne Sherwood, PhD.
Jim DeMase Sr. National Technical Sales Manager Precision BioLogic Inc. Dartmouth, Nova Scotia, CANADA Hemophilia is a disease that strikes rich and pour, royals or commoners. We will review the types, symptoms, and diagnosis and common treatment options available today. The laboratory testing methods and their clinical applications in laboratory test diagnosis will be outlined and new recombinant factor replacement products will be highlighted as they pose new challenges for the hemostasis lab. Case studies will be used to relate to real world situations. Objectives: Describe the types of Hemophilia that affect patients. Explain the range of Hemophilia symptoms along with diagnosis and treatment. Relate the methods and clinical applications for mixing studies and factor inhibitors. Workshop #2 Intermediate Subject Area – Hematology Wednesday, May 16 8:00 – 9:30 am 1.5 Contact Hours The Expanded CBC in Hematology: How Immature Cell Counts Help Complete the Patient Picture Robert Oleksy Senior Clinical Specialist Sysmex The clinical utilization of immature cell counts used in conjunction with mature cell count data may assist clinicians with assessing pathophysiological mechanisms and help complete the overall patient picture. This session will discuss newer hematology parameters currently available to clinicians outside of the standard Complete Blood Count (CBC). The presentation will include information on Immature Granulocyte (IG) percent and absolute counts, Reticulocyte Hemoglobin content, Immature Platelet Fraction (IPF) and Immature Platelet Count (IPC). The review will include clinical evidence and case studies related to the parameters and discuss the impact the authors found in their studies. Objectives: Describe novel hematology parameters and their derivation. Investigate the evidence for their clinical utility. Discuss how new information can be applied to patient care. Workshop #3 Intermediate Subject Area – Immunology Wednesday, May 16 8:00 – 9:30 am 1.5 Contact Hours Primary Immunodeficiency Disease: Underdiagnosed at any age Dr. Anne Sherwood, PhD.
HCLC+2018+Brochure.docx